Fidelity Management & Research

Fidelity Management & Research

Fidelity Management & Research

PE Hub , CrunchBase

VC-backed Moderna Therapeutics goes public

Forbes

Amazon Black Friday 2018: 23andMe DNA Test Gets A Steep Price Cut

Xconomy

Agbio Startup Cibus Files for an IPO to Support Gene-Editing R&D

PE Hub

Cibus files to go public

MedCity News

Moderna Therapeutics seeks $500M for IPO

$70,000,000 IPO
Xconomy

Twist Bioscience IPO Hauls In $70M for DNA Synthesis Technology

Earnings Funding Science
Re/code

23andMe CEO Anne Wojcicki says ‘one of our biggest competitors’ is fake science on sites like Goop

Adweek

Meet the Quirky Genes That Determine Who You Are in 23andMe's New Ad Campaign

TechCrunch

23andMe might soon offer a more comprehensive $749 DNA service

Apps & Services Science
Acquisition
FinSMEs , PE Hub

10x Genomics Acquires Epinomics

Science Funding
PE Hub

Outset Medical procures $132 mln Series D

Mashable

23andMe has pledged to follow new guidelines on how they handle people's DNA

Privacy Health
Fast Company

23AndMe and Ancestry want you to stop worrying about giving them your DNA

Technology
The Verge

23andMe and other DNA-testing firms promise not to share data without consent

Privacy
$300,000,000 Private equity
FinSMEs

23andMe Receives $300M Strategic Investment from GSK

Health Science
CNET

23andMe DNA results to be used by Glaxo for new drug research

Health Science
SiliconANGLE Media

GSK invests $300M into 23andme in return for four-year development partnership - SiliconANGLE

Funding
MIT Tech Review , Forbes

Drug giant invests $300 million in 23andMe and the promise of genetics

Health
Reuters , MedCity News

GSK's new R&D head bets on genetics with $300 million 23andMe deal

Earnings Health Science
$70,000,000 Venture capital (Series C)
Xconomy , FinSMEs

Cibus Raises $70M for Marketing of Gene-Edited Canola, More R&D

Funding